41 results
424B5
IMPLQ
Impel Pharmaceuticals Inc
5 Oct 23
Prospectus supplement for primary offering
5:19pm
supplement or related free writing prospectus to which we have referred you. Neither we nor TD Cowen take any responsibility for, and can provide … , and may face further scrutiny from the SEC.
Our reliance on third parties does not relieve us of our responsibility to ensure compliance with all required
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility … responsibility for the resolution of any UK Financial Institution.
“Willful Breach” has the meaning set forth in Section 8.19.
“Withdrawal
8-K
EX-10.1
IMPLQ
Impel Pharmaceuticals Inc
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
) having responsibility for the resolution of any EEA Financial Institution.
“Eligible Transferee” means and includes (i) any commercial bank, (ii) any … or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.
“Withdrawal Liability” means
NT 10-Q
obaufz
15 Aug 23
Notice of late quarterly filing
4:29pm
PRE 14A
dly0s2lf9a0 fis
14 Apr 23
Preliminary proxy
4:11pm
10-K/A
EX-3.2
8hofd0y hr5a6irf
31 Mar 23
Annual report (amended)
4:21pm
424B5
j3q4je
24 May 22
Prospectus supplement for primary offering
4:32pm
S-3
EX-5.1
jdoc j3cfjl3f80
16 May 22
Shelf registration
4:49pm
S-3
EX-1.2
faptal0pi8gm u29f
16 May 22
Shelf registration
4:49pm
S-3
EX-4.4
jvcg x20aenc1y
16 May 22
Shelf registration
4:49pm
S-3
fkpqunq
16 May 22
Shelf registration
4:49pm
DEF 14A
ydwp7v420 9skroygv2
26 Apr 22
Definitive proxy
4:16pm